Amedica to Announce Financial Results for the Second Quarter of 2014 on Thursday, August 7, 2014

SALT LAKE CITY, July 31, 2014 (GLOBE NEWSWIRE) -- Amedica Corporation (Nasdaq:AMDA), a biomaterial company focused on using its Silicon Nitride technology platform to develop, manufacture and sell a broad range of medical devices, announced today that it will release financial results for its second quarter 2014 on Thursday, August 7, 2014, at approximately 9:00 a.m. Eastern Time. A copy of the release will be available on the Amedica website at http://investors.amedica.com/releases.cfm. Following the release, the Company will host a conference call at 10:00 a.m. Eastern Time. 

Amedica invites all interested parties to join the call by dialing (855) 455-6055 for domestic participants and (484) 756-4308 for international participants. All callers will be asked to reference Conference ID number 82853935. The call will also be broadcast live over the Internet and can be accessed on the Investors section of the Company's website at http://investors.amedica.com. 

A telephone replay will be available for one week following the call by dialing (855) 859-2056 for domestic participants and (404) 537-3406 for international participants. When prompted, please enter the Conference ID number 82853935. For those who are not available to listen to the live webcast, the call will be archived on the investor relations section of the Amedica website under Events & Presentations. 

About Amedica Corporation

Amedica is a commercial biomaterial company focused on using its Silicon Nitride technology platform to develop, manufacture and sell a broad range of medical devices. Amedica markets spinal fusion products and is developing product candidates for use in total hip and knee joint replacements. Amedica operates an ISO 13485 certified manufacturing facility and its spine products are FDA cleared, CE marked, and currently marketed in the U.S. and select markets in Europe and South America.

The company's website for news releases and other information is www.amedica.com.

CONTACT: Investor Contact:
         Michael Houston
         Director of Investor Relations
         (801) 839-3535
         mhouston@amedica.com

Released July 31, 2014